Use and safety of rifaximin in children with inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 49, Issue 4, 2009, Pages 400-404

  Muniyappa, Pramodha ^a   Gulati, Reema ^a   Mohr, Franziska ^a   Hupertz, Vera ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

Antimicrobial therapy; Inflammatory bowel disease; Pediatrics; Rifaximin

Indexed keywords

RIFAXIMIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; ENTERITIS; FEMALE; HEMATOCHEZIA; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; ULCERATIVE COLITIS;

ABDOMINAL PAIN; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; DIARRHEA; FEMALE; GASTROINTESTINAL AGENTS; HEMORRHAGE; HUMANS; MALE; RETROSPECTIVE STUDIES; RIFAMYCINS; YOUNG ADULT;

EID: 70349751968     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181a0d269     Document Type: Article

References (16)

1. Hoover WW, Gerlach EH, Hoban DJ, et al. Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative. Diagn Microbiol Infect Dis 1993;16:111-118 (Pubitemid 23090031)
2. Gillis JC, Brogden RN. Rifaximin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria. Drugs 1995;49:467-484
3. Rizzello F, Gionchetti P, Venturi A, et al. Rifaximin systemic absorption in patients with ulcerative colitis. Eur J Clin Pharmacol 1998;54:91-93 (Pubitemid 28189406)
4. Steffen R, Sack DA, Riopel L, et al. Therapy of travelers' diarrhea with rifaximin on various continents. Am J Gastroenterol 2003; 98:1073-1078 (Pubitemid 36733769)
5. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics and prebiotics. Gastroenterology 2004;126:1620-1633
6. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995;108:1617-1621
7. Thia KT, Mahadevan U, Feagan BG, et al. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2009;15:17-24.
8. Inoue S, Nakase H, Matsuura M, et al. Open label trial of clarithromycin therapy in Japanese patients with Crohn's disease. J Gastroenterol Hepatol 2007;22:984-988 (Pubitemid 47019847)
9. Casparian JM, Luchi M, Moffat RE, et al. Quinolones and tendon ruptures. South Med J 2000;93:488-491
10. Prantera C, Berto E, Scribano ML, et al. Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin. Ital J Gastroenterol Hepatol 1998;30:602-606 (Pubitemid 29073996)
11. Prantera C, Zannoni F, Scribano ML, et al. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 1996;91:328-332 (Pubitemid 26067343)
12. Gionchetti P, Rizzello F, Ferrieri A, et al. Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial. Dig Dis Sci 1999;44: 1220-1221 (Pubitemid 29297232)
13. Shafran I, Johnson LK. An open-label evaluation of rifaximin in the treatment of active Crohn's Disease. Curr Med Res Opin 2005;21: 1165-1169 (Pubitemid 41140719)
14. Prantera C, Lochs H, Campieri M, et al. Antibiotic treatment of Crohn's disease: results of a multicentre double blind, randomized, placebo-controlled trial with rifaximin. Aliment Pharmacol Ther 2006;23:1117-1125 (Pubitemid 43779351)
15. Testa R, Eftimiadi C, Sukkar GS, et al. A non-absorbable rifamycin for treatment of hepatic encephalopathy. Drugs Exp Clin Res 1985; 11:387-392 (Pubitemid 15246073)
16. De Leo C, Eftimiadi C, Schito GC. Rapid disappearance from intestinal tract of bacteria resistant to rifaximin. Drugs Exp Clin Res 1986;12:979-981 (Pubitemid 17040185)